H
Henrik Irgens
Researcher at University of Bergen
Publications - 9
Citations - 1576
Henrik Irgens is an academic researcher from University of Bergen. The author has contributed to research in topics: Exome sequencing & Cohort study. The author has an hindex of 7, co-authored 9 publications receiving 1405 citations. Previous affiliations of Henrik Irgens include Haukeland University Hospital.
Papers
More filters
Journal ArticleDOI
Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study.
TL;DR: Genetic factors that increase the risk of cardiovascular disease may also be linked to pre-eclampsia, which occurs in 3-5% of pregnancies and is compatible with maternal genes for thrombophilia having an effect on therisk of pre- eClampsia and of death from cardiovascular disease.
Journal ArticleDOI
Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes
Jason Flannick,Nicola L. Beer,Alexander G. Bick,Alexander G. Bick,Vineeta Agarwala,Vineeta Agarwala,Janne Molnes,Namrata Gupta,Noël P. Burtt,Jose C. Florez,Jose C. Florez,James B. Meigs,Herman A. Taylor,Herman A. Taylor,Herman A. Taylor,Valeriya Lyssenko,Henrik Irgens,Henrik Irgens,Ervin R. Fox,Frank Burslem,Stefan Johansson,Stefan Johansson,M. Julia Brosnan,Jeff K. Trimmer,Christopher Newton-Cheh,Tiinamaija Tuomi,Tiinamaija Tuomi,Anders Molven,Anders Molven,James G. Wilson,Christopher J. O'Donnell,Sekar Kathiresan,Sekar Kathiresan,Joel N. Hirschhorn,Joel N. Hirschhorn,Joel N. Hirschhorn,Pål R. Njølstad,Pål R. Njølstad,Pål R. Njølstad,Tim Rolph,Jonathan G. Seidman,Stacey Gabriel,David R. Cox,Christine E. Seidman,Christine E. Seidman,Christine E. Seidman,Leif Groop,Leif Groop,David Altshuler +48 more
TL;DR: Accurate estimates of variant effect sizes from population-based sequencing are needed to avoid falsely predicting a substantial fraction of individuals as being at risk for MODY or other Mendelian diseases.
Journal ArticleDOI
Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry
Henrik Irgens,Janne Molnes,Janne Molnes,Bente B. Johansson,Bente B. Johansson,Monika Ringdal,Monika Ringdal,Torild Skrivarhaug,Dag E. Undlien,Oddmund Søvik,Geir Joner,Geir Joner,Anders Molven,Anders Molven,Pål R. Njølstad,Pål R. Njølstad,Pål R. Njølstad +16 more
TL;DR: This is the first prevalence study of the common forms of MD in a nationwide, population-based registry of childhood diabetes and found that 1.1% of patients in the Norwegian Childhood Diabetes Registry had MD.
Journal ArticleDOI
Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.
Pamela Bowman,Åsta Sulen,Åsta Sulen,Fabrizio Barbetti,Jacques Beltrand,Pernille Svalastoga,Pernille Svalastoga,Ethel Codner,Ellen H Tessmann,Petur Benedikt Juliusson,Petur Benedikt Juliusson,Torild Skrivarhaug,Ewan R. Pearson,Sarah E. Flanagan,Tarig Babiker,Nicholas J. Thomas,Maggie Shepherd,Sian Ellard,Iwar Klimes,Magdalena Szopa,Michel Polak,Dario Iafusco,Andrew T. Hattersley,Pål R. Njølstad,Pål R. Njølstad,Javier Aisenberg,Ilker Akkurt,Hussein Abdul-Latif,Anees Al-Abdullah,L Barak,Joop P. W. van den Bergh,Anne-Marie Bertrand,Carla Bizzarri,Riccardo Bonfanti,Henri Bruel,Anthony Burrows,Francesco Cadario,Fergus J. Cameron,Dennis Carson,Maryse Cartigny,Vittoria Cauvin,Hélène Cavé,Ali J. Chakera,Ravi Chetan,Giovanni Chiari,Bob Couch,Régis Coutant,Elizabeth Cummings,Adriana Dankovcikova,Liz Davis,Dorothee Deiss,Maurizio Delvecchio,Elena Faleschini,Anne-Laure Fauret,Roisin Finn,Tamsin Ford,Elisa De Franco,Bastian De Gallen,Daniela Gasperikova,Padma Guntamukkala,Vaseem Hakeem,Shinji Hasegawa,Eba Hathout,Emmeline Heffernan,David Hill,Josephine Ho,Marie Hoarau,Reinhard W. Holl,Rebecca Hoddinott,Jane Houghton,Neville J. Howard,Natalie Hughes,Ian Hunter,Anne Kirsti Høgåsen,Helena Kuulasmaa,Sorin Ioacara,Violeta Iotova,Henrik Irgens,Alan Jaap,Kenneth Jones,Thomas Kapellen,Ellen Kaufman,Andreas Klinge,Tomasz Klupa,Ramaiyer Krishnaswamy,Tony Lafferty,Laurent Legault,Paul Lambert,Maciej T. Malecki,Olag Malievsky,Revi Mathew,Frances Mathews,Robert McVie,Ulrike Menzel,Chantale Metz,John Van Der Meulen,Gita Modgil,Dick Mul,Silvia Muther,Roos Nuboer,Susan M. O’Connell,Stephen Mp O’Riordan,Miroslav Palko,Kashyap A. Patel,Roberta Pesavento,Elvira Piccinno,Janani Kumaraguru Pillai,Stephanka Pruhova,Zubin Punthakee,Ivana Rabbone,Klemens Raile,Marielisa Rincon,Danette Rose,Janine Sanchez,Susan Sandereson,Vinay Saxena,Martin Schebek,Dorothee Schmidt,Naim Shehadeh,Julian P.H. Shiels,Jose M. C. L Silva,Juraj Stanik,Tracy Tinklin,Erling Tjora,Stefano Tumini,Tiinamaija Tuomi,Akiko Uehara,Robert Y. van der Velde,Guido Vermeulen,Uma Visser,Paul Voorhoeve,Jan L Walker,Jaques Weill,Tobias Weisner,Andrea Werner,Toni Williams,Helen J Woodhead,Rønnaug øddegård +137 more
TL;DR: Ten-year multicentre follow-up study of a large international cohort of patients with KCNJ11 permanent neonatal diabetes to address the key questions relating to long-term efficacy and safety of sulfonylureas in these patients, with main outcomes of interest sulfONYlurea failure, defined as permanent reintroduction of daily insulin, and metabolic control, specifically HbA1c and sulfonyLurea dose.
Journal ArticleDOI
Exome sequencing and genetic testing for MODY.
Stefan Johansson,Stefan Johansson,Henrik Irgens,Henrik Irgens,Kishan K. Chudasama,Kishan K. Chudasama,Janne Molnes,Jan Aerts,Jan Aerts,Francisco S. Roque,Inge Jonassen,Shawn Levy,Kari Lima,Per M. Knappskog,Per M. Knappskog,Graeme I. Bell,Anders Molven,Anders Molven,Pål R. Njølstad,Pål R. Njølstad +19 more
TL;DR: The results demonstrate that exome sequencing can improve molecular diagnostics of MODY when used as a complement to Sanger sequencing, however, improvements will be needed, especially concerning coverage, before the full potential of exome Sequencing can be realized.